Product Description
- BrandAbbott
- Sample TypeNasopharyngeal
- Pack Size10T
- CAT No62FK10
COVID-19 and Influenza have similar symptoms, making differential diagnosis difficult. Using one nasopharyngeal swab, the Panbio COVID-19/Flu A&B Rapid Panel simultaneously tests for COVID-19, Influenza A, and Influenza B, with results in 15 minutes. Ideal for testing many people quickly in general practice offices, point-of-care sites, workplaces, pharmacies, and schools/universities. Make actionable decisions quickly to help prevent the spread of illness.
Efficient Simultaneous Respiratory Virus DetectionThe Abbott PANBIO panel streamlines testing by detecting COVID-19, Influenza A, and Influenza B in one go. This multi-target capability minimizes test time, sample handling, and consumables, making it suitable for busy medical settings. Results are interpreted visually in under 20 minutes, supporting timely patient management and infection control decisions.
High Accuracy and User-Friendly OperationEngineered for reliability, this panel boasts sensitivity rates above 91% for all viruses and specificity nearing 99%. The simple swab-based collection and manual process require minimal training, making it accessible to healthcare professionals. The included instructions ensure clear guidance for each testing step, reinforcing result confidence even in high-demand environments.
Portable Design with Practical PackagingEach kit conveniently packages 25 single-use tests, complete with collection swabs, reagents, and devices in a compact box. The lightweight design and robust 18-month shelf life enhance storage and portability. No special equipment or wall mounting is required-just store the kit at 2C to 30C, away from direct sunlight, for optimal performance.
FAQ's of Abbott PANBIO COVID-19/FLU A&B RAPID PANEL (NASOPHARYNGEAL):
Q: How does the Abbott PANBIO COVID-19/FLU A&B Rapid Panel work?
A: This rapid test uses lateral flow immunoassay technology to qualitatively detect antigens from SARS-CoV-2, Influenza A, and Influenza B in nasopharyngeal samples. Healthcare professionals collect a sample using the provided swab, process it with the included reagents, and apply it to the test device. Results are displayed as visual lines within 15-20 minutes.
Q: What type of sample is required for this test?
A: The panel requires a nasopharyngeal swab specimen. Each kit includes sterile swabs and extraction tubes designed specifically for safe and effective collection of these upper respiratory samples.
Q: When should this test be used?
A: The Abbott PANBIO panel is intended for rapid, point-of-care testing in healthcare settings when patients present with symptoms of respiratory infection. Early use can help distinguish between COVID-19, Influenza A, and Influenza B, aiding swift treatment and isolation decisions.
Q: Where can the Abbott PANBIO panel be utilized?
A: This test is suitable for use in various healthcare environments, including hospitals, outpatient clinics, medical offices, and testing stations. It does not require wall mounting or any specialized equipment, making it highly portable and adaptable.
Q: What benefits does this rapid panel provide over traditional methods?
A: The primary advantage is simultaneous detection of three major respiratory viruses in a single test with results in as little as 15 minutes. With high accuracy and minimal sample handling, it significantly accelerates diagnosis and patient management compared to laboratory-based PCR tests.
Q: How should the test kits be stored and handled?
A: Store the kits at temperatures between 2C and 30C and keep them away from direct sunlight. All testing components are single-use, and the kit remains effective for up to 18 months from the manufacturing date, as long as storage instructions are followed.